SwePub
Sök i LIBRIS databas

  Extended search

L773:1522 1210 OR L773:0031 9333
 

Search: L773:1522 1210 OR L773:0031 9333 > The Sick and the We...

  • Friedrich, O (author)

The Sick and the Weak: Neuropathies/Myopathies in the Critically Ill

  • Article/chapterEnglish2015

Publisher, publication year, extent ...

  • American Physiological Society,2015

Numbers

  • LIBRIS-ID:oai:prod.swepub.kib.ki.se:131982509
  • http://kipublications.ki.se/Default.aspx?queryparsed=id:131982509URI
  • https://doi.org/10.1152/physrev.00028.2014DOI

Supplementary language notes

  • Language:English
  • Summary in:English

Part of subdatabase

Classification

  • Subject category:ref swepub-contenttype
  • Subject category:art swepub-publicationtype

Notes

  • Critical illness polyneuropathies (CIP) and myopathies (CIM) are common complications of critical illness. Several weakness syndromes are summarized under the term intensive care unit-acquired weakness (ICUAW). We propose a classification of different ICUAW forms (CIM, CIP, sepsis-induced, steroid-denervation myopathy) and pathophysiological mechanisms from clinical and animal model data. Triggers include sepsis, mechanical ventilation, muscle unloading, steroid treatment, or denervation. Some ICUAW forms require stringent diagnostic features; CIM is marked by membrane hypoexcitability, severe atrophy, preferential myosin loss, ultrastructural alterations, and inadequate autophagy activation while myopathies in pure sepsis do not reproduce marked myosin loss. Reduced membrane excitability results from depolarization and ion channel dysfunction. Mitochondrial dysfunction contributes to energy-dependent processes. Ubiquitin proteasome and calpain activation trigger muscle proteolysis and atrophy while protein synthesis is impaired. Myosin loss is more pronounced than actin loss in CIM. Protein quality control is altered by inadequate autophagy. Ca2+dysregulation is present through altered Ca2+homeostasis. We highlight clinical hallmarks, trigger factors, and potential mechanisms from human studies and animal models that allow separation of risk factors that may trigger distinct mechanisms contributing to weakness. During critical illness, altered inflammatory (cytokines) and metabolic pathways deteriorate muscle function. ICUAW prevention/treatment is limited, e.g., tight glycemic control, delaying nutrition, and early mobilization. Future challenges include identification of primary/secondary events during the time course of critical illness, the interplay between membrane excitability, bioenergetic failure and differential proteolysis, and finding new therapeutic targets by help of tailored animal models.

Added entries (persons, corporate bodies, meetings, titles ...)

  • Reid, MB (author)
  • Van den Berghe, G (author)
  • Vanhorebeek, I (author)
  • Hermans, G (author)
  • Rich, MM (author)
  • Larsson, LKarolinska Institutet (author)
  • Karolinska Institutet (creator_code:org_t)

Related titles

  • In:Physiological reviews: American Physiological Society95:3, s. 1025-11091522-12100031-9333

Internet link

Find in a library

To the university's database

Search outside SwePub

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view